Dexcom (DXCM) Non-Current Assets (2010 - 2026)
Dexcom's (DXCM) quarterly Non-Current Assets came in at $2.3 billion in Q1 2026, up 4.72% year-on-year from $2.2 billion in Q1 2025, and little changed on a QoQ basis from $2.3 billion in Q4 2025.
Dexcom (DXCM) Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has 17 years of Non-Current Assets data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 4.72% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $9.2 billion, a 9.06% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 5.66% from the prior year.
- Non-Current Assets for Q1 2026 stood at $2.3 billion, roughly flat from $2.3 billion in the prior quarter.
- Over the last five years, Non-Current Assets for DXCM reached as high as $2.3 billion in Q4 2025 and fell as low as $1.3 billion in Q1 2022.
- Historically, Non-Current Assets has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2023.
- Across the five-year window, Non-Current Assets soared 38.71% in 2022 and climbed 4.72% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $1.7 billion in 2022, then climbed by 6.72% to $1.8 billion in 2023, then increased by 18.74% to $2.2 billion in 2024, then grew by 5.66% to $2.3 billion in 2025, then retreated by 0.22% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $2.3 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 8.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Bn |
| Dec 31, 2025 | 2.31 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.30 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.18 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.86 Bn |
| Dec 31, 2023 | 1.84 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.75 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.12 Bn |
| Jun 30, 2021 | 1.03 Bn |